John W. Smither - 29 Dec 2023 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ Louise Kooij by Power of Attorney for John W. Smither
Issuer symbol
NAMS
Transactions as of
29 Dec 2023
Net transactions value
$0
Form type
3
Filing time
29 Dec 2023, 16:30:27 UTC
Previous filing
28 Dec 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAMS Option (right to buy) 29 Dec 2023 Ordinary Shares 18,600 $10.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 14, 2023. 25% of the shares underlying the option will vest on the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney